Study: Switching to ENDS Reduces Health Risks Associated With Smoke Exposure

Innovation by Vaping Post
Jul.18.2022
A recent study published in NIH found that electronic nicotine delivery systems (ENDS) seem to cause less bronchial epithelial cells toxicity in comparison to cigarettes.

Titled, “Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project,” the study aimed to replicate three published studies looking and comparing the cytotoxic and inflammatory effects of cigarette smoke and ENDS aerosol, in an independent multi-center ring study.

Study: Switching to ENDS Reduces Health Risks Associated With Smoke Exposure

 

The research team established the reliability of results and the robustness of conclusions by replicating the authors’ experimental protocols and then also validating via different methods. After human bronchial epithelial cells (NCI-H292) were exposed to cigarette smoke and e-cig vapour, the researchers assessed the inflammatory cytokines interleukin-6 and interleukin-8 and the remodeling mediator matrix metalloproteinase-1.

 

The researchers confirmed that almost 80% of cytotoxic effects are due to volatile compounds in the vapor phase of smoke. To this effect, they confirmed the reduced cytotoxic effects of ENDS aerosol. However, the data gathered on inflammatory and remodeling activity triggered by smoke differed significantly from those in the original reports. Considering the independent data gathered from multiple laboratories, the study confirmed the reduced toxicity of ENDS compared to cigarettes.

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

 

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
State Tobacco Monopoly Administration Chief Meets with President of South Korean Tobacco Company Wang Gongcheng also in attendance; friendly talks held between the two parties.
State Tobacco Monopoly Administration Chief Meets with President of South Korean Tobacco Company Wang Gongcheng also in attendance; friendly talks held between the two parties.
State Tobacco Monopoly Administration director Zhang Jianmin met with Korean Tobacco Company president Fang Jingwan in Beijing on October 31.
Nov.03 by 2FIRSTS.ai
Product | GEEK BAR and Canada’s STLTH Co-Launch 80,000-Puff Vape, Now Available Across Multiple Channels
Product | GEEK BAR and Canada’s STLTH Co-Launch 80,000-Puff Vape, Now Available Across Multiple Channels
Canada’s STLTH has teamed up with GEEK BAR to launch the disposable “STLTH X GEEK BAR 80K,” featuring 30 ml of e-liquid and up to 80,000 puffs. The device is now available across multiple retail channels in Canada, priced around C$44.99–48.99.
Oct.30 by 2FIRSTS.ai
2Firsts Investigation | China–U.S. E-cigarette Shipping Costs Surge: Sea Freight Up Over 200%, Air Cargo Inspection Rate Exceeds 50%
2Firsts Investigation | China–U.S. E-cigarette Shipping Costs Surge: Sea Freight Up Over 200%, Air Cargo Inspection Rate Exceeds 50%
Since late July, China–U.S. e-cigarette shipping costs have surged — sea freight up over 200%, air cargo inspection rates exceeding 50%. 2Firsts investigates the key drivers behind the spike and how the industry is responding.
Oct.15
ceshi
ceshi
Nov.04
Smoking Among Korean Men in Their 30s Plummets as E-Cigarettes Become the Main Substitute
Smoking Among Korean Men in Their 30s Plummets as E-Cigarettes Become the Main Substitute
KDCA reports cigarette smoking among Korean men in their 30s fell from 48% (2015) to 28.5% (2024). Including e-cigarettes, overall use was 40.1% in 2024—just 4.9 points below 2019—suggesting a shift to alternatives.
Oct.09 by 2FIRSTS.ai